Apparently Ferring Pharmaceuticals has finally been able to get Firmagon® approved as the new trade (brand) name for degarelix (their new LHRH antagonist) here in the USA. This is the same brand name as is used in Europe. Who knows why it took so long! The media release doesn’t say.
In other news reports today we comment on studies dealing with:
- Vitamin B-6 and prostate cancer-specific survival
- Tallness and prostate cancer risk
- Quality of care indicators for prostate cancer studies … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: Degarelix, Height, quality of care, survival, tallness, vitamin B-6 | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 